Search Results 91-100 of 15838 for lewy body dementia
A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies. Print details. Share; Facebook · Twitter.
The purpose of this study is to assess the safety and tolerability of CT1812 as a treatment for mild-to-moderate Dementia with Lewy Bodies. Participation ...
Mayo Clinic's clinical trials related to brain aging and memory include studies of Alzheimer's disease, Lewy body dementia, frontotemporal dementia, ...
In this video, Dr. Dickson describes Lewy body dementia and Mayo Clinic studies that this research award supports.
... Lewy body dementia, frontotemporal dementia and related disorders. Alzheimer's disease research at Mayo Clinic is distinguished by the depth and breadth of ...
... Lewy body dementia. A Study to Evaluate Quantitative Phenotypes of Movement Disorders Jacksonville, FL. The purpose of this study is to determine if adaptive ...
Frontotemporal dementia; Gerstmann-Straussler-Scheinker syndrome; Hashimoto's encephalopathy; Huntington's disease · Hydrocephalus · Lewy body dementia · Mild ...
Researchers found that the imaging from patients with dementia with Lewy bodies and Alzheimers disease differed significantly from that of patients in the ...
Woodruff, M.D.. Neurologist. Phoenix, AZ. Areas of focus: Mild cognitive impairment, Dementia, Alzheimer's disease, Frontotemporal dementia, Lewy body dementia, ...
... dementia, especially frontotemporal dementia and Lewy body dementia. Scientists study people with these dementias over time and in clinical trials ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.